HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lois E H Smith Selected Research

cytochrome P-450 CYP2C subfamily

11/2016Fenofibrate Inhibits Cytochrome P450 Epoxygenase 2C Activity to Suppress Pathological Ocular Angiogenesis.
1/2016Cytochrome P450 Oxidase 2C Inhibition Adds to ω-3 Long-Chain Polyunsaturated Fatty Acids Protection Against Retinal and Choroidal Neovascularization.
3/2014Cytochrome P450 2C8 ω3-long-chain polyunsaturated fatty acid metabolites increase mouse retinal pathologic neovascularization--brief report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lois E H Smith Research Topics

Disease

32Retinopathy of Prematurity (Retrolental Fibroplasia)
03/2022 - 07/2003
21Pathologic Neovascularization
01/2020 - 01/2007
15Retinal Neovascularization
01/2017 - 07/2003
12Hypoxia (Hypoxemia)
01/2017 - 08/2005
10Macular Degeneration (Age-Related Maculopathy)
01/2020 - 09/2010
9Premature Birth (Birth, Premature)
01/2021 - 11/2003
8Diabetic Retinopathy (Retinopathy, Diabetic)
01/2021 - 01/2009
7Choroidal Neovascularization
01/2020 - 01/2015
7Eye Diseases (Eye Disease)
01/2018 - 11/2011
5Neoplasms (Cancer)
06/2021 - 02/2011
5Ischemia
01/2016 - 07/2003
4Birth Weight (Birth Weights)
10/2021 - 11/2003
4Inflammation (Inflammations)
01/2020 - 10/2012
4Blindness (Hysterical Blindness)
01/2020 - 01/2005
4Weight Gain
01/2017 - 12/2006
3Hemorrhage
01/2021 - 01/2016
3Hyperoxia
10/2013 - 07/2003
2Hyperglycemia
03/2022 - 01/2016
2Brain Injuries (Brain Injury)
01/2020 - 01/2016
2Necrosis
01/2017 - 08/2010
2Vascular Diseases (Vascular Disease)
08/2012 - 02/2008
1Neurodevelopmental Disorders
06/2022
1Retinitis Pigmentosa (Pigmentary Retinopathy)
11/2021
1Neoplasm Metastasis (Metastasis)
06/2021
1Uveitis
06/2021
1Ocular Hypertension (Glaucoma, Suspect)
06/2021
1Retinal Degeneration
04/2021
1Epiretinal Membrane (Epiretinal Membranes)
01/2021
1Optic Nerve Diseases (Optic Neuropathy)
01/2017
1Type 2 Diabetes Mellitus (MODY)
11/2016
1Telangiectasis (Telangiectasia)
04/2016
1Retinal Diseases
04/2016
1Neuroinflammatory Diseases
01/2016
1Necrotizing Enterocolitis
01/2016
1Bronchopulmonary Dysplasia
01/2016
1Colorectal Neoplasms (Colorectal Cancer)
01/2015

Drug/Important Bio-Agent (IBA)

32Retinaldehyde (Retinal)IBA
03/2022 - 07/2003
23Oxygen (Dioxygen)IBA
01/2020 - 07/2003
16Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 07/2002
14Insulin-Like Growth Factor I (IGF-1)IBA
01/2021 - 11/2003
9Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
03/2022 - 02/2011
9LipidsIBA
01/2021 - 02/2011
5Insulin-Like PeptidesIBA
01/2021 - 05/2009
5ErythropoietinFDA Link
01/2019 - 02/2008
5Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2013 - 06/2006
4Fatty Acids (Saturated Fatty Acids)IBA
03/2022 - 07/2007
4Messenger RNA (mRNA)IBA
01/2020 - 08/2005
3Arachidonic Acid (Vitamin F)IBA
10/2021 - 01/2018
3AdiponectinIBA
01/2017 - 04/2015
3cytochrome P-450 CYP2C subfamilyIBA
11/2016 - 03/2014
3Cytochrome P-450 CYP2C8IBA
11/2016 - 03/2014
3Insulin (Novolin)FDA Link
01/2014 - 06/2006
3Insulin-Like Growth Factor Binding Protein 3IBA
01/2013 - 12/2006
2Docosahexaenoic AcidsIBA
10/2021 - 01/2021
2fibroblast growth factor 21IBA
04/2021 - 01/2017
2Carrier Proteins (Binding Protein)IBA
01/2021 - 01/2019
2Pharmaceutical PreparationsIBA
01/2019 - 03/2009
2VLDL LipoproteinsIBA
01/2017 - 04/2011
219,20-epoxydocosapentaenoic acidIBA
11/2016 - 03/2014
2Proteins (Proteins, Gene)FDA Link
03/2016 - 06/2006
2Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
01/2016 - 03/2014
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
10/2015 - 07/2003
2Sirtuin 1IBA
01/2014 - 10/2013
2PPAR gammaIBA
01/2013 - 08/2010
1ORALIT (ORS)IBA
10/2021
1SteroidsIBA
06/2021
1Neuroprotective AgentsIBA
04/2021
1CreatineIBA
01/2021
1sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
01/2021
1FructoseIBA
01/2020
1cupric sulfide (CuS)IBA
01/2020
1Interleukin-6 (Interleukin 6)IBA
01/2020
1Nonesterified Fatty Acids (NEFA)IBA
01/2020
1Phosphotransferases (Kinase)IBA
01/2020
1PF-05231023IBA
01/2018
1Ranibizumab (Lucentis)FDA Link
01/2018
1Fish OilsIBA
08/2017
1EmulsionsIBA
08/2017
1Hemoglobins (Hemoglobin)IBA
06/2017
1G-Protein-Coupled Receptor Kinase 1 (G Protein-Coupled Receptor Kinase 1)IBA
01/2017
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
11/2016
1Fenofibrate (CiL)FDA LinkGeneric
11/2016
1Glucose (Dextrose)FDA LinkGeneric
04/2016
1Tyrosine (L-Tyrosine)FDA Link
03/2016
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
03/2016
1montelukast (Singulair)FDA Link
01/2016
1Oxidoreductases (Dehydrogenase)IBA
01/2016
1LigandsIBA
10/2015
1phosducinIBA
10/2015
1Methionine (L-Methionine)FDA Link
10/2015
1DNA (Deoxyribonucleic Acid)IBA
01/2015
1CalcineurinIBA
01/2015

Therapy/Procedure

7Therapeutics
06/2021 - 06/2010
7Lasers (Laser)
01/2020 - 04/2009
3Aftercare (After-Treatment)
06/2021 - 01/2005
1Rehabilitation
06/2022
1Drug Therapy (Chemotherapy)
06/2021
1Radiotherapy
06/2021
1Parenteral Nutrition
01/2017
1Slit Lamp
01/2015